Skip to main content
Top
Published in: Journal of Gastroenterology 4/2020

01-04-2020 | Esophageal Cancer | Original Article—Alimentary Tract

High incidence of head and neck cancers after endoscopic resection for esophageal cancer in younger patients

Authors: Akira Maekawa, Ryu Ishihara, Taro Iwatsubo, Kentaro Nakagawa, Masayasu Ohmori, Hiroyoshi Iwagami, Kenshi Matsuno, Shuntaro Inoue, Masamichi Arao, Hiroko Nakahira, Noriko Matsuura, Satoki Schichijo, Takashi Kanesaka, Sachiko Yamamoto, Yoji Takeuchi, Koji Higashino, Noriya Uedo, Takashi Fujii, Toshitaka Morishima, Isao Miyashiro

Published in: Journal of Gastroenterology | Issue 4/2020

Login to get access

Abstract

Background

Second cancers in patients with esophageal cancer (EC) are common and have a poor prognosis. We evaluated the incidence of second cancers at different sites by patients’ ages when their index ECs were diagnosed.

Methods

This study included patients who underwent endoscopic resection for superficial EC at our hospital between September 1994 and September 2011. Patients’ data, including sex, age at diagnosis, sequence of cancer incidence, cancer histology, and cancer site, were extracted from the cancer registry.

Results

Of 544 patients, 255 developed second cancers. Simultaneous head and neck cancers (HNCs) and other organ cancers (OCs) were, respectively, present in 15% (80/544) and 9.6% (52/544) of patients; and 30% (162/544) developed metachronous second cancers over a median follow-up period of 79.5 months (range 2–120), including 44 metachronous HNCs and 70 OCs. The cumulative incidence of metachronous HNCs was significantly higher in younger patients (< 60 years) than in older patients (≥ 60 years; P = 0.001), whereas the cumulative incidence of OCs was significantly higher in older patients than in younger patients (P = 0.03).

Conclusions

The incidence of second HNC after index EC was higher in younger-onset patients than in older-onset patients. We suggest that younger patients with EC should be carefully monitored for early detection of second HNC.
Literature
1.
go back to reference Torre LA, Bray F, Siegel RL, et al. Global cancer statistics. 2012. CA Cancer J Clin. 2015;65:87. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics. 2012. CA Cancer J Clin. 2015;65:87.
2.
go back to reference Hori M, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the monitoring of Cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884–91.CrossRef Hori M, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the monitoring of Cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884–91.CrossRef
3.
go back to reference Tachimori Y, Ozawa S, Numasaki H, et al. The Registration Committee for Esophageal Cancer of the Japan Esophageal Society: comprehensive Registry of Esophageal Cancer in Japan 2009. Esophagus. 2016;13:110–37.CrossRef Tachimori Y, Ozawa S, Numasaki H, et al. The Registration Committee for Esophageal Cancer of the Japan Esophageal Society: comprehensive Registry of Esophageal Cancer in Japan 2009. Esophagus. 2016;13:110–37.CrossRef
4.
go back to reference Yamashina T, Ishihara R, Nagai K, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol. 2013;108:544–51.CrossRef Yamashina T, Ishihara R, Nagai K, et al. Long-term outcome and metastatic risk after endoscopic resection of superficial esophageal squamous cell carcinoma. Am J Gastroenterol. 2013;108:544–51.CrossRef
5.
go back to reference Ishihara R, Tanaka H, Iishi H, et al. Long-term outcome of esophageal mucosal squamous cell carcinoma without lymphovascular involvement after endoscopic resection. Cancer. 2008;112:2166–72.CrossRef Ishihara R, Tanaka H, Iishi H, et al. Long-term outcome of esophageal mucosal squamous cell carcinoma without lymphovascular involvement after endoscopic resection. Cancer. 2008;112:2166–72.CrossRef
6.
go back to reference Shibuya H, Wakita T, Nakagawa T, et al. The relation between an esophageal cancer and associated cancers in adjacent organs. Cancer. 1995;76:101–5.CrossRef Shibuya H, Wakita T, Nakagawa T, et al. The relation between an esophageal cancer and associated cancers in adjacent organs. Cancer. 1995;76:101–5.CrossRef
7.
go back to reference Chuang SC, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer. 2008;123:2390–6.CrossRef Chuang SC, Scelo G, Tonita JM, et al. Risk of second primary cancer among patients with head and neck cancers: a pooled analysis of 13 cancer registries. Int J Cancer. 2008;123:2390–6.CrossRef
8.
go back to reference Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer. 1953;6:963–98.CrossRef Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer. 1953;6:963–98.CrossRef
9.
go back to reference Secretan B, Straif K, Baan R, et al. A review of human carcinogens–part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10:1033–4.CrossRef Secretan B, Straif K, Baan R, et al. A review of human carcinogens–part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10:1033–4.CrossRef
10.
go back to reference Kato M, Ishinara R, Hamada K, et al. Endoscopic surveillance of head and neck cancer in patients with esophageal squamous cell carcinoma. Endoscopy Int Open. 2016;04:E752–E755755.CrossRef Kato M, Ishinara R, Hamada K, et al. Endoscopic surveillance of head and neck cancer in patients with esophageal squamous cell carcinoma. Endoscopy Int Open. 2016;04:E752–E755755.CrossRef
11.
go back to reference Iwatsubo T, Ishinaha R, Morishima T, et al. Impact of age at diagnosis of head and neck cancer on incidence of metachronous Cancer. BMC Cancer. 2019;19:3.CrossRef Iwatsubo T, Ishinaha R, Morishima T, et al. Impact of age at diagnosis of head and neck cancer on incidence of metachronous Cancer. BMC Cancer. 2019;19:3.CrossRef
12.
go back to reference International Classification of Diseases for Oncology, 3rd ed, first revision. Geneva: World Health Organization; 2013. International Classification of Diseases for Oncology, 3rd ed, first revision. Geneva: World Health Organization; 2013.
13.
go back to reference Katada C, Yokoyama T, Yano T, et al. Alcohol consumption and multiple dysplastic lesions increase risk of squamous cell carcinoma in the esophagus, head, and neck. Gastroenterology. 2016;151:860–9.CrossRef Katada C, Yokoyama T, Yano T, et al. Alcohol consumption and multiple dysplastic lesions increase risk of squamous cell carcinoma in the esophagus, head, and neck. Gastroenterology. 2016;151:860–9.CrossRef
14.
go back to reference SEER Program Code Manual, 3rd ed. Bethesda: National Cancer Institute; 1998. SEER Program Code Manual, 3rd ed. Bethesda: National Cancer Institute; 1998.
15.
go back to reference Hori M, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884–91.CrossRef Hori M, Matsuda T, Shibata A, et al. Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 2015;45:884–91.CrossRef
16.
go back to reference Tabuchi T, Ito Y, Ioka A, et al. Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data. Cancer Sci. 2012;103:1111–20.CrossRef Tabuchi T, Ito Y, Ioka A, et al. Incidence of metachronous second primary cancers in Osaka, Japan: update of analyses using population-based cancer registry data. Cancer Sci. 2012;103:1111–20.CrossRef
17.
go back to reference Yokoyama A, Ohmori T, Muramatsu T, et al. Cancer screening of upper aerodigestive tract in Japanese alcoholics with reference to drinking and smoking habits and aldehyde dehydrogenase-2 genotype. Int J Cancer. 1996;68:313–6.CrossRef Yokoyama A, Ohmori T, Muramatsu T, et al. Cancer screening of upper aerodigestive tract in Japanese alcoholics with reference to drinking and smoking habits and aldehyde dehydrogenase-2 genotype. Int J Cancer. 1996;68:313–6.CrossRef
18.
go back to reference Goedde HW, Agarwal DP, Fritze G, et al. Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet. 1992;8:344–6. Goedde HW, Agarwal DP, Fritze G, et al. Distribution of ADH2 and ALDH2 genotypes in different populations. Hum Genet. 1992;8:344–6.
Metadata
Title
High incidence of head and neck cancers after endoscopic resection for esophageal cancer in younger patients
Authors
Akira Maekawa
Ryu Ishihara
Taro Iwatsubo
Kentaro Nakagawa
Masayasu Ohmori
Hiroyoshi Iwagami
Kenshi Matsuno
Shuntaro Inoue
Masamichi Arao
Hiroko Nakahira
Noriko Matsuura
Satoki Schichijo
Takashi Kanesaka
Sachiko Yamamoto
Yoji Takeuchi
Koji Higashino
Noriya Uedo
Takashi Fujii
Toshitaka Morishima
Isao Miyashiro
Publication date
01-04-2020
Publisher
Springer Singapore
Published in
Journal of Gastroenterology / Issue 4/2020
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-019-01653-y

Other articles of this Issue 4/2020

Journal of Gastroenterology 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.